Gender disparities in HIV health care utilization among the severely disadvantaged: Can we determine the reasons?

AIDS Patient Care and STDs

Volumn 23, Issue 9, 2009, Pages 775-783

  Sohler, Nancy L ^a,b   Li, Xuan ^b   Cunningham, Chinazo O ^b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIMARY MEDICAL CARE; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE;

ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; INTERVIEWS AS TOPIC; MALE; NEW YORK CITY; PRIMARY HEALTH CARE; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; TRUST; YOUNG ADULT;

EID: 70349207398     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2009.0041     Document Type: Article

References (61)

1. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001; 135:17-26.
2. Nash D, Katyal M, Shah S. Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001. J Urban Health 2005;82:584-600.
3. Mayor AM, Gomez MA, Rios-Oliveras E, Hunter-Mellado RF. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons. Ethn Dis 2005;15(4 Suppl 5):S57-62.
4. Giordano TP, White AC Jr, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003;32:399-405.
5. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1499.
6. Clarke S, Delamere S, McCullough L, Hopkins S, Bergin C, Mulcahy F. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med 2003;4:33-37.
7. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14: 357-366.
8. Knowlton AR, Hoover DR, Chung SE, et al. Access to medical care and service utilization among injection drug users with HIV= AIDS. Drug Alcohol Depend 2001;64:55-62.
9. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
10. Welch KJ, Morse A. Survival patterns among HIV+individuals based on health care utilization. J Natl Med Assoc 2001;93:214-219.
11. Cunningham WE, Andersen RM, Katz MH, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care 1999;37: 1270-1281.
12. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073-1076.
13. Kaiser Family Foundation. HIV= AIDS Policy Fact Sheet. The HIV= AIDS epidemic in the United States. July 2007. www .kff.org= hivaids= upload= 3029-071.pdf (Last accessed February 12, 2009).
14. Health Resources and Services Administration, HIV= AIDS Bureau. Outreach, Engaging People in HIV Care. August 2006. ftp:==ftp.hrsa.gov=hab=HIVoutreach. pdf (Last accessed February 12, 2009).
15. New York City HIV=AIDS Annual Surveillance Statistics. New York: New York City Department of Health and Mental Hygiene , 2007. Updated September 30, 2008. www.nyc.gov=html=doh=downloads=pdf=dires=surveillance2007-table1.1 .pdf (Last accessed February 12, 2009).
16. Turner BJ, Cunningham WE, Duan N, et al. Delayed medical care after diagnosis in a U.S. national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000;160:2614-2622.
17. Wong MD, Cunningham WE, Shapiro MF, et al. Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med 2004;19:366-374.
18. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005;38:96-103.
19. Cunningham WE, Hays RD, Williams KW, et al. Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med Care 1995;33:739-754.
20. Diamant, AL, Hays RD, Morales L, et al. Delays and unmet need for health care among adult primary care patients in a restructured urban public health system. Am J Public Health 2004;94:783-789.
21. Rumptz MH, Tobias C, Rajabiun S, et al. Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDs 2007;21(Suppl 1):S30-39.
22. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. N Engl J Med 1998; 339:1897-1904.
23. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
24. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.
25. Lucas GM, Cheever LW, Chaisson RE, et al. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001;27:251-259.
26. Lucas GM, Gebo KA, Chaisson RE, et al. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16:767-774.
27. Palepu A, Horton NJ, Tibbetts N, et al. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction 2004;99:361-368.
28. Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health 2004;94:1207-1217.
29. Centers for Disease Control and Prevention. HIV=AIDS Surveillance Report, 2005, Volume 17, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006. www.cdc.gov=hiv= topics=surveillance=resources=reports= (last accessed February 12, 2009).
30. Doescher MP, Saver BG, Franks P, et al. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med 2000;9:1156-1163.
31. Parchman ML, Burge SK. The patient-physician relationship, primary care attributes, and preventive services. Fam Med 2004;36:22-27.
32. O'Malley AS, Sheppard VB, Schwartz M, et al. The role of trust in use of preventive services among low-income African-American women. Prev Med 2004;38:777-785.
33. Hall MA, Zheng B, Dugan E, et al. Measuring patients' trust in their primary care providers. Med Care Res Rev 2002; 59:293-318.
34. Anderson LA, Dedrick RF. Development of the Trust in Physician scale: A measure to assess interpersonal trust in patient-physician relationships. Psych Rep 1990;67:1091-1100.
35. Safran DG, Taira DA, Rogers WH, et al. Linking primary care performance to outcomes of care. J Fam Pract 1998; 47:213-220.
36. Thom DH, Ribisl KM, Stewart AL, et al. Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care 1999;37:510-517.
37. Schneider J, Kaplan SH, Greenfield S, et al. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-1103.
38. Piette JD, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med 2005;165:1749-1755.
39. Centers for Disease Control and Prevention. HIV=AIDS Surveillance Report, 2006. Volume 18. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. www.cdc.gov=hiv= topics=surveillance=resources=reports= (Last accessed February 12, 2009).
40. Centers for Disease Control and Prevention. HIV=AIDS Surveillance Report, 2007. Volume 19. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2009. www.cdc.gov=hiv= topics=surveillance=resources=reports= (Last accessed July 24, 2009).
41. Mechanic D, Greenley JR. Sex differences in medical care utilization: an empirical investigation. J Health Soc Behav 1982;23:106-119.
42. Hibbard JH, Pope CR. Gender roles, illness orientation and use of medical services. Soc Sci Med 1983;17:129-137.
43. Waldron I. Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med 1983;17: 1107-1123.
44. Verbrugge LM, Wingard DL. Sex differentials in health and mortality. Women Health 1987;12:103-145.
45. Perlis TE, Des Jarlais DC, Friedman SR, et al. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction 2004;99:885-896.
46. Katz LM, Cumming PD, Wallace EL, et al. Audiovisual touch-screen computer-assisted self-interviewing for donor health histories: Results from two years experience with the system. Transfusion 2005;45:171-180.
47. Newman JC, Des Jarlais DC, Turner CF, et al. The Differential Effects of Face-to-Face and Computer Interview Modes. Am J Public Health 2002;92:294-297.
48. McLellan AT, Luborsky L, O'Brien CP, et al. An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. J Nerv Mental Dis 1980;168: 26-33.
49. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
50. Safran DG, Kosinski M, Tarlov AR, et al. The Primary Care Assessment Survey: Tests of data quality and measurement performance. Med Care 1998;36:728-739.
51. Bakken S, Holzemer WL, Brown M-A, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV= AIDS. AIDS Patient Care STDs 2000;14:189-197.
52. Weinman J, Petrie KJ, Moss-Morris R, et al. The Illness Perception Questionnaire: A new method for assessing illness perceptions. Psych Health 1996;11:431-446.
53. Department of Health and Human Services. The Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. October 6, 2005.
54. Schuster MA, Kanouse DE, Morton SC, et al. HIV-infected parents and their children in the United States. Am J Public Health 2000;90:1074-1081.
55. Schulz R, Sherwood PR. Physical and mental health effects of family caregiving. Am J Nurs 2008;108(9 Suppl): 23-27.
56. Wolff JL, Dy SM, Frick KD, et al. End of-life care: Findings from a national survey of informal caregivers. Arch Intern Med 2007;167:40-46.
57. Fredman L, Cauley JA, Satterfield S, et al. Caregiving, mortality, and mobility decline: The Health, Aging, and Body Composition (Health ABC) Study. Arch Intern Med 2008;168:2154-2162.
58. Arno PS, Levine C, Memmott MM. The economic value of informal caregiving. Health Aff 1999;18:182-188.
59. Ware NC, Wyatt MA, Tugenberg T. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Soc Sci Med 2005;61:565-576.
60. Remien RH, Hirky AE, Johnson MO, et al. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+men and women in four U.S. cities. AIDS Behav 2004;7:61-72.
61. Riley ED, Gandhi M, Hare CB, Cohen J, Hwang SW. Poverty, unstable housing, and HIV infection among women living in the United States. Curr HIV=AIDS Rep 2007;4:181-186.